These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 33516339)

  • 1. Widespread soft tissue calcification in systemic sclerosis, polymyositis, and polyarthritis.
    Hudowenz O; Klemm P; Lange U; Mueller-Ladner U
    Lancet; 2021 Jan; 397(10272):409. PubMed ID: 33516339
    [No Abstract]   [Full Text] [Related]  

  • 2. Successful use of baricitinib in the treatment of refractory rheumatoid arthritis-associated Sweet syndrome.
    Nousari Y; Wu BC; Valenzuela G
    Clin Exp Dermatol; 2021 Oct; 46(7):1330-1332. PubMed ID: 33914946
    [No Abstract]   [Full Text] [Related]  

  • 3. Herpes simplex infection in a patient with rheumatoid arthritis treated with baricitinib: a case report.
    Valor-Méndez L; Voskens C; Rech J; Kleyer A; Schett G
    Rheumatology (Oxford); 2021 Apr; 60(4):e122-e123. PubMed ID: 33141876
    [No Abstract]   [Full Text] [Related]  

  • 4. Repigmentation of vitiligo with oral baricitinib.
    Mumford BP; Gibson A; Chong AH
    Australas J Dermatol; 2020 Nov; 61(4):374-376. PubMed ID: 32491188
    [No Abstract]   [Full Text] [Related]  

  • 5. Successful treatment with baricitinib in a patient with refractory cutaneous dermatomyositis.
    Delvino P; Bartoletti A; Monti S; Biglia A; Montecucco C; Carducci M; Ripamonti G; Cavagna L
    Rheumatology (Oxford); 2020 Dec; 59(12):e125-e127. PubMed ID: 32353871
    [No Abstract]   [Full Text] [Related]  

  • 6. Inhibition of Progression of Acrodermatitis Continua of Hallopeau With Baricitinib.
    Han GM; Yang WS; Yang B
    JAMA Dermatol; 2021 Apr; 157(4):466-468. PubMed ID: 33656520
    [No Abstract]   [Full Text] [Related]  

  • 7. Baricitinib: A chance to treat COVID-19?
    Lo Caputo S; Corso G; Clerici M; Santantonio TA
    J Med Virol; 2020 Nov; 92(11):2343-2344. PubMed ID: 32437019
    [No Abstract]   [Full Text] [Related]  

  • 8. Successful treatment of spondyloenchondrodysplasia with baricitinib.
    Shimizu M; Inoue N; Mizuta M; Irabu H; Okajima M; Honda Y; Nihira H; Izawa K; Yachie A; Wada T
    Rheumatology (Oxford); 2021 Feb; 60(2):e44-e46. PubMed ID: 32856090
    [No Abstract]   [Full Text] [Related]  

  • 9. Massive nodulous lesions on hands and feet in a RA patient and improvement under baricitinib treatment.
    Valor-Méndez L; Hagen M; Kleyer A; Manger B; Schett G
    RMD Open; 2020 Nov; 6(3):. PubMed ID: 33214327
    [No Abstract]   [Full Text] [Related]  

  • 10. Dupilumab-induced enthesoarthritis and refractory atopic dermatitis successfully treated with baricitinib.
    De Stefano L; Bobbio-Pallavicini F; Montecucco C; Bugatti S
    Rheumatology (Oxford); 2022 Mar; 61(3):e64-e66. PubMed ID: 34647989
    [No Abstract]   [Full Text] [Related]  

  • 11. Other rheumatic diseases in adolescence. Dermatomyositis, scleroderma, overlap syndromes, systemic vasculitis, and panniculitis.
    Hom C; Ilowite NT
    Adolesc Med; 1998 Feb; 9(1):69-83, vi. PubMed ID: 10961253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytomegalovirus Enteritis in a Patient with Rheumatoid Arthritis Receiving Baricitinib.
    Sugawara E; Matsui K; Amasaki Y
    J Rheumatol; 2020 Dec; 47(12):1835-1836. PubMed ID: 33262287
    [No Abstract]   [Full Text] [Related]  

  • 13. Successful treatment of joint and fascial chronic graft-versus-host disease with baricitinib.
    Shimizu M; Shimbo A; Takagi M; Eguchi K; Ishimura M; Sugita J; Morio T; Kanegane H
    Rheumatology (Oxford); 2021 Dec; 61(1):e1-e3. PubMed ID: 34302457
    [No Abstract]   [Full Text] [Related]  

  • 14. Use of Janus kinase inhibitors in COVID-19: a prospective observational series in 522 individuals.
    Melikhov O; Kruglova T; Lytkina K; Melkonyan G; Prokhorovich E; Putsman G; Rodoman G; Vertkin A; Zagrebneva A; Stebbing J
    Ann Rheum Dis; 2021 Sep; 80(9):1245-1246. PubMed ID: 34099486
    [No Abstract]   [Full Text] [Related]  

  • 15. Corticosteroids in Myositis and Scleroderma.
    Postolova A; Chen JK; Chung L
    Rheum Dis Clin North Am; 2016 Feb; 42(1):103-18, ix. PubMed ID: 26611554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Case report: Peristomal pyoderma gangrenosum complicated by rheumatoid arthritis and Behçet's disease successfully treated with baricitinib.
    Ito H; Noda K; Saruta M; Kurosaka D
    Int J Rheum Dis; 2024 Jul; 27(7):e15275. PubMed ID: 39046183
    [No Abstract]   [Full Text] [Related]  

  • 17. Successful treatment with baricitinib of refractory arthritis in a patient with severe diffuse cutaneous systemic sclerosis-rheumatoid arthritis overlap syndrome.
    Boleto G; Cren JB; Avouac J; Allanore Y
    Clin Exp Rheumatol; 2021; 39 Suppl 131(4):163-164. PubMed ID: 34251322
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of baricitinib in patients with alopecia areata: Usefulness of trichoscopic evaluation.
    Diluvio L; Matteini E; Lambiase S; Cioni A; Gaeta Shumak R; Dattola A; Bianchi L; Campione E
    J Eur Acad Dermatol Venereol; 2024 Jun; 38(6):e478-e480. PubMed ID: 38084867
    [No Abstract]   [Full Text] [Related]  

  • 19. Baricitinib treatment in children with COPA syndrome.
    Matucci-Cerinic C; Corona F; Varnier GC; Pastore S; Bocca P; Palmeri S; Ravelli A; Caorsi R; Gattorno M; Tommasini A; Volpi S
    J Allergy Clin Immunol Pract; 2024 Aug; 12(8):2201-2204. PubMed ID: 38768895
    [No Abstract]   [Full Text] [Related]  

  • 20. Baricitinib in Alopecia Areata.
    Messenger A; Harries M
    N Engl J Med; 2022 May; 386(18):1751-1752. PubMed ID: 35507486
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.